COVID-19 pandemic
The Italian Medicines Agency approves the administration of a third dose of the COVID-19 vaccine to clinically vulnerable people using the MRNA-based Pfizer and Moderna vaccines.
Sources: ANSA
Changes
- The Italian Medicines Agency approves the usage of a third dose of the COVID-19 vaccine using MRNA-based Pfizer and Moderna vaccines to clinically vulnerable population.
- The Italian Medicines Agency approves the administration of a third dose of the COVID-19 vaccine to clinically vulnerable people using the MRNA-based Pfizer and Moderna vaccines.